Daily non-political popular news in brief.

Kidney Progress: Drug slows cyst growth

The trial drug roscovitine has been shown to reverse polycystic kidney disease in mice.

Read more »

Keywords: kidney, progress, drug, slows, cyst, growth, slow

« Previous | Next »

Similar news on "Kidney Progress: Drug slows cyst growth":

1. Breakthrough MS treatment doesn't reach US patients
   04-04-2007 · EurekAlert!
   Many US multiple sclerosis (MS) patients aren't receiving the latest drug therapies, according to research published in the online journal BMC Medicine. Immunomodulatory agents (IMAs) could slow the progress of the disease, but are only prescribed in a minority of cases, and mostly by neurologists.
   Similar news · Read more »
   
2. Allergy drug slows pancreatic tumor growth in preclinical studies
   12-19-2006 · EurekAlert!
   An anti-allergy drug in use for more than 40 years significantly reduced tumor growth in animal models of human pancreatic cancer and also increased the effectiveness of standard chemotherapy, say researchers at the University of Texas M. D. Anderson Cancer Center.
   Similar news · Read more »
   
3. Cancer drug can extend survival in patients with deadly brain tumors
   02-20-2007 · EurekAlert!
   Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.
   Similar news · Read more »
   
4. Drug slows prostate tumor growth by keeping vitamin A active
   11-06-2007 · EurekAlert!
   A novel compound that blocks the breakdown of retinoic acid, derived from vitamin A, is a surprisingly effective and "promiscuous" agent in treating animal models of human prostate cancer, say investigators from the University of Maryland, Baltimore.
   Similar news · Read more »
   
5. A new pharmaceutical drug that halts progress of metastatic kidney cancer
   03-01-2007 · EurekAlert!
   Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.
   Similar news · Read more »
   
6. Drug combination effective against multiple myeloma, researchers show
   11-21-2007 · EurekAlert!
   Pairing a new thalidomide derivative with a steroid slows progress of multiple myeloma, an incurable bone marrow cancer, and prolongs the lives of patients who have relapsed from previous treatment, researchers report in the Nov. 22 New England Journal of Medicine.
   Similar news · Read more »
   
7. Paracetamol, one of most used analgesics, could slow down bone growth
   09-03-2007 · EurekAlert!
   UGR scientists stress the need for controlling the use of paracetamol, as it has been proved "in vitro" that it slows down bone regeneration. Their work has demonstrated that applying plasma rich in growth factors, from the patients themselves and applied on the bones, accelerates cell growth. Therefore, it could also be used to regenerate wounds or ulcers when applied over soft tissue. Results of this research have been published in prestigious journals such as Bioscience Reports, Oral Diseases and Physiology and Biochemistry among others.
   Similar news · Read more »
   
8. Drug treatment slows macular vision loss in diabetics
   12-15-2006 · EurekAlert!
   A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, Johns Hopkins Wilmer Eye Institute scientists report.
   Similar news · Read more »
   
9. Support for chromosomal theory of cancer found in cancers' development of drug resistance
   06-27-2007 · EurekAlert!
   Most cancer researchers are convinced that cancer results from a handful of genetic mutations that kick a cell into uncontrolled growth. UC Berkeley genetics researcher Peter Duesberg disagrees, and finds support for his "chromosomal" theory of cancer in the development of drug resistance by many cancers. While his theory implies their is no magic bullet against cancer, it does provide ways to detect cancer at an early stage.
   Similar news · Read more »
   
10. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
    01-31-2008 · EurekAlert!
    Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
    Similar news · Read more »